Connective tissue disease-associated interstitial lung disease.

There was no difference in adding pirfenidone to the mycophenolate regimen in an 18-month period, and both groups showed improvements in FVC% when compared with placebo, although the combination mycophenolate plus pirfenidone presented with a more rapid improvement over 6 months and showed a trend toward fewer fibrosis areas on HRCT.

also in 53,322 other papers